Search Results

Showing results 51 - 60 of 1771.
Sort By: Date ▼

FDA approved a flu drug that can cut symptoms by 33 hours—but will patients use it?

October 25, 2018

FDA approved Genentech's antiviral influenza treatment Xofluza, which is a member of a new class of drugs called endonuclease inhibitors that disrupt the viral replication process, preventing viruses from replicating and spreading infections.

Is the 'tide turning' on the opioid epidemic? Trump admin, rolling out new efforts, says yes.

October 25, 2018

The Trump administration this week announced new efforts to combat the U.S. opioid epidemic, as President Trump signed into law a sweeping, bipartisan bill to address opioid misuse.

FDA sets new record for generic drug approvals

October 25, 2018

FDA data show the agency approved 781 generic drugs in fiscal year (FY) 2018, breaking the agency's previous record of 763 generic drug approvals in FY 2017.

In first, immunotherapy shows promise in treating aggressive breast cancer

October 23, 2018

A study for the first time finds that a new immunotherapy showed positive results against triple-negative breast cancer, prompting some health care providers to express cautious optimism about the drug's ability to prolong survival.

The 50 most influential health care leaders, according to Time

October 19, 2018

Time's inaugural Health Care 50 list recognizes the industry's most influential movers and shakers—including FDA Commissioner Scott Gottlieb and other policymakers.

PCSK9 drugs can save lives—but a pricing 'battle' is undercutting patient access

October 18, 2018

PCSK9 inhibitors, a new class of drugs that help reduce cholesterol levels, can be life-saving for some patients—but many do not have access to the drugs because of their extremely high prices.

The 5 fears that keep doctors up at night

October 17, 2018

From politics to financial concerns, Robert Pearl, a surgeon and former CEO of the Permanente Medical Group, in a Forbes article breaks down the "five intense fears" plaguing doctors today.

Trump admin wants drugmakers to disclose prices in drug ads—but PhRMA has its own idea

October 16, 2018

CMS under a newly proposed rule would require prescription drugmakers to include their products' list prices in direct-to-consumer television advertisements, but Pharmaceutical Research and Manufacturers of America says the proposed rule raises legal questions, and its members instead will direct consumers to company websites with pricing information for their products.

Results Page: [Previous] ... 6 7 8 9 10  ... [Next]